Medicine and Dentistry
Cystic Fibrosis
100%
Patient
54%
Lung
49%
Sputum
34%
Infection
30%
Pseudomonas aeruginosa
25%
Therapeutic Procedure
23%
Pathogen
21%
Antiinfective Agent
21%
Bronchiectasis
20%
Adult
20%
Analysis
16%
Microbiome
16%
Bacterium
15%
Anti-biotics
15%
Culture
14%
In Vitro
13%
Lung Clearance
11%
Ivacaftor
10%
Chronic Obstructive Pulmonary Disease
10%
Development
10%
Patient with Cystic Fibrosis
10%
Diseases
9%
Antibiogram
8%
Respiratory Tract Infection
8%
Tissues
8%
Silo-Filler's Disease
8%
Child
7%
Breathing
7%
Burkholderia Cepacia Complex
7%
Chemotherapy
7%
Methicillin Resistant Staphylococcus Aureus
7%
Inpatient
7%
Species
7%
Lung Infection
7%
Antibiotic Therapy
6%
Mortality
6%
Assessment
6%
Clinical Trial
6%
Inflammation
6%
Protein
6%
Survival
5%
Chest
5%
Host
5%
Combination Therapy
5%
Azithromycin
5%
Transplantation
5%
Tobramycin
5%
Respiratory Tract Inflammation
5%
Consensus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
84%
Antiinfective Agent
73%
Pseudomonas aeruginosa
45%
Infection
35%
Infectious Agent
31%
Antibiotic Agent
27%
Tobramycin
26%
Antibiotics
22%
Bacterium
21%
Chemotherapy
18%
Prevotella
12%
Methicillin-Resistant Staphylococcus Aureus
12%
Microflora
11%
Ceftazidime
10%
Lung Infection
9%
Staphylococcus
9%
Methylthioninium Chloride
8%
Antibiotic Resistance
8%
Bronchiectasis
8%
Chronic Obstructive Lung Disease
8%
Photosensitizer
8%
Extended Spectrum Beta Lactamase
8%
Burkholderia Cepacia Complex
7%
Tetrazolium
7%
Microbiome
7%
Respiratory Tract
7%
Murepavadin
7%
Fosfomycin
7%
Gentamicin
7%
Carbon Tetrachloride
7%
Biomaterial
6%
Drug
6%
Penicillinase
5%
Minimum Inhibitory Concentration
5%
Antimicrobial Resistance
5%
Implant
5%
Virulence
5%
Inhalation
5%
Anaerobic Bacterium
5%
Polymer
5%
Immunology and Microbiology
Lung
60%
Sputum
38%
Sample
36%
Pseudomonas aeruginosa
34%
Microflora
31%
Biofilm
19%
Infectious Agent
18%
Bacterium
18%
Taxon
18%
Species
16%
Microbiome
16%
Antibiotic Sensitivity
15%
Anaerobic Bacterium
15%
Gene
14%
Inflammation
13%
Antimicrobial Resistance
13%
Minimum Inhibitory Concentration
12%
Prevotella
11%
Time
10%
Pseudomonas
9%
Genus
9%
Streptococcus
9%
Mutation
9%
Health
8%
Anaerobe
7%
Reduction (Chemistry)
7%
Association
6%
Tissues
6%
Mortality
6%
Density
6%
Urine
6%
Growth
6%
Position
5%
Veillonella
5%
Virulence
5%
Lung Clearance
5%
Modulation
5%
Total Viable Count
5%
Methicillin-Resistant Staphylococcus Aureus
5%
Development
5%
Comprehension
5%
Haemophilus influenzae
5%